Shanghai Synvida Biotechnology Co.,ltd.

This early-phase study tests a new drug called SV001 in 53 healthy Chinese adults to see if it is safe and how the body processes it. Participants receive a single dose of SV001 or a placebo. The goal is to check for side effects and measure drug levels in the blood. This is a fi…

This study tests a new drug, SV001, in 48 adults with idiopathic pulmonary fibrosis (IPF), a disease that causes lung scarring and makes breathing hard. The main goal is to check if SV001 is safe and how the body processes it. Participants will receive either SV001 or a placebo, …

This early-stage trial is testing a new drug called SV003 in 60 healthy volunteers to see if it is safe and how the body processes it. Participants receive a single dose of either SV003 or a placebo. The study is not designed to treat any disease but to gather important safety an…